These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 14871915)
1. A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. Lynch HT; Coronel SM; Okimoto R; Hampel H; Sweet K; Lynch JF; Barrows A; Wijnen J; van der Klift H; Franken P; Wagner A; Fodde R; de la Chapelle A JAMA; 2004 Feb; 291(6):718-24. PubMed ID: 14871915 [TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575 [TBL] [Abstract][Full Text] [Related]
3. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801 [TBL] [Abstract][Full Text] [Related]
4. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer. Froggatt NJ; Green J; Brassett C; Evans DG; Bishop DT; Kolodner R; Maher ER J Med Genet; 1999 Feb; 36(2):97-102. PubMed ID: 10051005 [TBL] [Abstract][Full Text] [Related]
5. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation]. Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain. Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650 [TBL] [Abstract][Full Text] [Related]
7. MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population. Chan TL; Chan YW; Ho JW; Chan C; Chan AS; Chan E; Lam PW; Tse CW; Lee KC; Lau CW; Gwi E; Leung SY; Yuen ST Am J Hum Genet; 2004 May; 74(5):1035-42. PubMed ID: 15042510 [TBL] [Abstract][Full Text] [Related]
8. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610 [TBL] [Abstract][Full Text] [Related]
9. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene. Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003 [TBL] [Abstract][Full Text] [Related]
10. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Ponz de Leon M; Benatti P; Di Gregorio C; Pedroni M; Losi L; Genuardi M; Viel A; Fornasarig M; Lucci-Cordisco E; Anti M; Ponti G; Borghi F; Lamberti I; Roncucci L Br J Cancer; 2004 Feb; 90(4):882-7. PubMed ID: 14970868 [TBL] [Abstract][Full Text] [Related]
11. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees. Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790 [TBL] [Abstract][Full Text] [Related]
12. Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutation. Green J; O'Driscoll M; Barnes A; Maher ER; Bridge P; Shields K; Parfrey PS Dis Colon Rectum; 2002 Sep; 45(9):1223-32. PubMed ID: 12352241 [TBL] [Abstract][Full Text] [Related]
13. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis. de Leon MP; Pedroni M; Benatti P; Percesepe A; Di Gregorio C; Foroni M; Rossi G; Genuardi M; Neri G; Leonardi F; Viel A; Capozzi E; Boiocchi M; Roncucci L Gut; 1999 Jul; 45(1):32-8. PubMed ID: 10369701 [TBL] [Abstract][Full Text] [Related]
14. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016 [TBL] [Abstract][Full Text] [Related]
15. Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes. Pensotti V; Radice P; Presciuttini S; Calistri D; Gazzoli I; Grimalt Perez A; Mondini P; Buonsanti G; Sala P; Rossetti C; Ranzani GN; Bertario L; Pierotti MA Genes Chromosomes Cancer; 1997 Jul; 19(3):135-42. PubMed ID: 9218993 [TBL] [Abstract][Full Text] [Related]
16. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044 [TBL] [Abstract][Full Text] [Related]
17. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge. Ponti G; Manfredini M; Tomasi A; Pellacani G Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115 [TBL] [Abstract][Full Text] [Related]
18. Origins and prevalence of the American Founder Mutation of MSH2. Clendenning M; Baze ME; Sun S; Walsh K; Liyanarachchi S; Fix D; Schunemann V; Comeras I; Deacon M; Lynch JF; Gong G; Thomas BC; Thibodeau SN; Lynch HT; Hampel H; de la Chapelle A Cancer Res; 2008 Apr; 68(7):2145-53. PubMed ID: 18381419 [TBL] [Abstract][Full Text] [Related]
19. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471 [TBL] [Abstract][Full Text] [Related]
20. Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype. Pérez-Cabornero L; Borrás Flores E; Infante Sanz M; Velasco Sampedro E; Acedo Becares A; Lastra Aras E; Cuevas González J; Pineda Riu M; Ramón y Cajal Asensio T; Capellá Munar G; Miner Pino C; Durán Domínguez M Cancer Prev Res (Phila); 2011 Oct; 4(10):1546-55. PubMed ID: 21778331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]